| PALVELLA THERAPEUTICS NEW |
| USA |
| Gesundheit |
| US6979471090 / A40RA6 |
| PI6 (Frankfurt) / PVLA (NASDAQ) |
| FRA:PI6, ETR:PI6, PI6:GR, NASDAQ:PVLA |
| - |
| https://palvellatx.com/ |
|
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for serious, rare skin diseases and vascular malformations with no FDA-approved treatment options. The company centers its w..
>Volltext.. |
| 1609.04 Mio. EUR |
| 1409.19 Mio. EUR |
| - |
| -51.54 Mio. EUR |
| -55.07 Mio. EUR |
| -4.32 EUR |
| 20.21 Mio. EUR |
| 167.65 Mio. EUR |
| -32.59 Mio. EUR |
| 20.97 |
| -100% |
| -142.94% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.671.486 Euro. |
| PALVELLA |
| 28.10.26 |
|